Drug Profile
Interferon-alpha - GeneTrol Biotherapeutics
Alternative Names: SuperFeronLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator GeneTrol Biotherapeutics
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Cytokine modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Viral infections
Most Recent Events
- 29 Oct 2001 Preclinical development for Cancer in USA (Unknown route)
- 29 Oct 2001 Preclinical development for Viral infections in USA (Unknown route)